Terajima, Jun Izumiya, Hidemasa Hara-Kudo, Yukiko and Ohnishi, Makoto 2017. Shiga Toxin (Verotoxin)-producing<i>Escherichia coli</i> and Foodborne Disease:A Review. Food Safety, Vol. 5, Issue. 2, p. 35.
Russo, Lisa M. Melton-Celsa, Angela R. and O'Brien, Alison D. 2016. Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a. Journal of Infectious Diseases, Vol. 213, Issue. 8, p. 1271.
Mishra, Raghavendra Prasad Jain, Udit Bist, Basanti Verma, Amit Kumar and Kumar, Ashok 2016. Prevalence of vero toxic Escherichia coli in fecal samples of domestic as well as wild ruminants in Mathura districts and Kanpur zoo. Veterinary World, Vol. 9, Issue. 1, p. 71.
Betzen, Christian Plotnicki, Kathrin Fathalizadeh, Farnoosh Pappan, Kirk Fleming, Thomas Bielaszewska, Martina Karch, Helge Tönshoff, Burkhard and Rafat, Neysan 2016. Shiga Toxin 2a–Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis. Journal of Infectious Diseases, Vol. 213, Issue. 6, p. 1031.
Ozaki, Masayuki Kang, Yulin Tan, Ying Siow Pavlov, Vasile I. Liu, Bohan Boyle, Daniel C. Kushak, Rafail I. Skjoedt, Mikkel-Ole Grabowski, Eric F. Taira, Yasuhiko and Stahl, Gregory L. 2016. Human mannose-binding lectin inhibitor prevents Shiga toxin–induced renal injury. Kidney International, Vol. 90, Issue. 4, p. 774.
Arimitsu, Hideyuki Sasaki, Keiko Iba, Yoshitaka Kurosawa, Yoshikazu Shimizu, Toshiyasu and Tsuji, Takao 2015. Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2. Microbiology and Immunology, Vol. 59, Issue. 2, p. 71.
Mele, Caterina Remuzzi, Giuseppe and Noris, Marina 2014. Hemolytic uremic syndrome. Seminars in Immunopathology, Vol. 36, Issue. 4, p. 399.
Arimitsu, Hideyuki Sasaki, Keiko Shimizu, Takeshi Tsukamoto, Kentaro Shimizu, Toshiyasu and Tsuji, Takao 2013. Large-scale preparation of Shiga toxin 2 inEscherichia colifor toxoid vaccine antigen production. Microbiology and Immunology, Vol. 57, Issue. 1, p. 38.
Petruzziello-Pellegrini, Tania N. Yuen, Darren A. Page, Andrea V. Patel, Sajedabanu Soltyk, Anna M. Matouk, Charles C. Wong, Dennis K. Turgeon, Paul J. Fish, Jason E. Ho, J.J. David Steer, Brent M. Khajoee, Vahid Tigdi, Jayesh Lee, Warren L. Motto, David G. Advani, Andrew Gilbert, Richard E. Karumanchi, S. Ananth Robinson, Lisa A. Tarr, Phillip I. Liles, W. Conrad Brunton, James L. and Marsden, Philip A. 2012. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin–associated hemolytic uremic syndrome in humans and mice. Journal of Clinical Investigation, Vol. 122, Issue. 2, p. 759.
Landoni, Verónica I. Schierloh, Pablo de Campos Nebel, Marcelo Fernández, Gabriela C. Calatayud, Cecilia Lapponi, María J. Isturiz, Martín A. and Bradley, Kenneth A. 2012. Shiga Toxin 1 Induces on Lipopolysaccharide-Treated Astrocytes the Release of Tumor Necrosis Factor-alpha that Alter Brain-Like Endothelium Integrity. PLoS Pathogens, Vol. 8, Issue. 3, p. e1002632.
Bergan, Jonas Dyve Lingelem, Anne Berit Simm, Roger Skotland, Tore and Sandvig, Kirsten 2012. Shiga toxins. Toxicon, Vol. 60, Issue. 6, p. 1085.
Mohawk, Krystle L. and O'Brien, Alison D. 2011. Mouse Models ofEscherichia coliO157:H7 Infection and Shiga Toxin Injection. Journal of Biomedicine and Biotechnology, Vol. 2011, p. 1.
Liu, Yue-Nan Wang, Sheng-han Li, Tao Wang, Qin Tu, Wei Cai, Kun Hou, Xiao-Jun Tian, Ren-Mao Gao, Xiang Liu, Hao Xiao, Le Shi, Jing Cheng, Yuan-Guo Li, Jian-Chun and Wang, Hui 2011. Shiga toxin type 2 (Stx2), a potential agent of bioterrorism, has a short distribution and a long elimination half-life, and induces kidney and thymus lesions in rats. Archives of Toxicology, Vol. 85, Issue. 9, p. 1133.
Black, E.P. Hirneisen, K.A. Hoover, D.G. and Kniel, K.E. 2010. Fate ofEscherichia coliO157:H7 in ground beef following high-pressure processing and freezing. Journal of Applied Microbiology, Vol. 108, Issue. 4, p. 1352.
Saenz, Jose B. Li, Jinmei and Haslam, David B. 2010. The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response. Cellular Microbiology, Vol. 12, Issue. 4, p. 516.
McLaine, Peter N Rowe, Peter C and Orrbine, Elaine 2009. Experiences with HUS in Canada: what have we learned about childhood HUS in Canada?. Kidney International, Vol. 75, p. S25.
Gu, Jiang Liu, Yanqing Yu, Shu Wang, Haiguang Wang, Qingxu Yi, Yong Zhu, Fengcai Yu, Xue-jie Zou, Quanming and Mao, Xuhu 2009. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice. Microbes and Infection, Vol. 11, Issue. 10-11, p. 835.
Tsuji, Takao Shimizu, Takeshi Sasaki, Keiko Shimizu, Yoshiyasu Tsukamoto, Kentaro Arimitsu, Hideyuki Ochi, Sadayuki Sugiyama, Satoshi Taniguchi, Koki Neri, Paola and Mori, Hiroshi 2008. Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin. Vaccine, Vol. 26, Issue. 4, p. 469.
Fifty-four strains of Escherichia coli belonging to serogroup O 157 were examined for the production of Vero cytotoxins VT1 and VT2, and for other properties such as plasmid content, resistance to antimicrobial agents and colicin production. Twenty-six strains from cases of diarrhoea, haemorrhagic colitis and haemolytic uraemic syndrome in humans produced VT. By serum neutralization tests and hybridization with DNA probes for VTl or VT2, three classes were recognized which produced either VTl alone or VT2 alone or both VTl and VT2. These strains were of H type 7 or non-motile. The strains producing VT were sensitive to all the antimicrobial agents tested, and all carried at least one plasmid which had a molecular weight of c.60 × 106. Seven strains of porcine origin and 21 strains of human origin did not produce VT or hybridize with either DNA probe. None of these strains was of H type 7. Of the 21 human VT” strains, 17 were of extraintestinal origin and 18 were of H type 45. Twenty-three of the 28 VT” strains were resistant to at least one antimicrobial agent.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 21st January 2018. This data will be updated every 24 hours.